,Key,Value
0,identifier, N/A
1,collection_site, N/A
2,specimen_type, N/A
3,name, John Doe
4,contact_info, N/A
5,birth_date, N/A
6,gender, Male
7,zip_code, N/A
8,us_core_race, White
9,us_core_birth_sex, Male
10,us_core_ethnicity, N/A
11,death_date, N/A
12,evidence_type, N/A
13,tumor_identifier, N/A
14,body_location, lung
15,longest_dimension, N/A
16,other_dimension, N/A
17,staging_method, N/A
18,lymphoma_stage, N/A
19,t_category, N/A
20,n_category, N/A
21,m_category, N/A
22,stage_type, N/A
23,asserted_date, 2023-01-10
24,histology/morphology, Non-Small Cell Lung Cancer (NSCLC)
25,body_site, N/A
26,secondary_cancer_condition, N/A
27,test_type, N/A
28,result_value, N/A
29,medication, EGFR Tyrosine Kinase Inhibitors (TKIs)
30,reason, N/A
31,procedure_intent, N/A
32,satus_reason, N/A
33,medicaiton, pembrolizumab
34,status_reason, N/A
35,procedure_code, N/A
36,number_of_sessions, N/A
37,modality, N/A
38,technique, N/A
39,total_dose, N/A
40,number_of_fractions, N/A
41,volume_type, N/A
42,radiotherapy_volumn, N/A
43,history_of_metastatic_cancer, N/A
44,comorbidities, N/A
45,remonic_variant, N/A
46,variation_code, N/A
47,genomic_hgvs, N/A
48,coding_change_type, N/A
49,protein_hgvs, N/A
50,amino_acid_change_type, N/A
51,molucular_consequence, N/A
52,cytogen_nomemclature, N/A
53,gene_studied," EGFR, TP53, KRAS, PDL1"
54,genomic_source_class, N/A
55,copy_number, N/A
56,allelic_frequency, N/A
57,allelic_state, N/A
58,cytogenetic_location, N/A
59,gene_mutations," EGFR mutation, TP53 mutation"
60,coordinate_system, N/A
61,ranges_examined, N/A
62,region_description, N/A
63,reference_sequence, N/A
